Investment
Features
FeesSafety
Academy
More
Pluang+

Compare QUALCOMM, Inc. (QCOM) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

QUALCOMM, Inc.Trade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

QUALCOMM, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? QUALCOMM, Inc. trades at $171.6 (market cap $188.86B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: QUALCOMM, Inc. is far larger — about 104.9× Vir Biotechnology Inc. Common Stock's market cap, and QUALCOMM, Inc. pays a 2.08% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold QUALCOMM, Inc. for 87 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

QCOMVIR
Market Cap
$188.86B$1.80B
Volume
12,280,7161,782,836
Sector
TechnologyHealth
52-Week High
$251.10$11.78
52-Week Low
$124.07$5.12
Typical Hold Time
87 Days0 Days
Enterprise Value
$195.82B$1.36B
Dividend Yield
2.08%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

QUALCOMM, Inc.

Qualcomm (QCOM) trades at $174.43, down 0.61% today, with a bearish technical signal despite recent AI-driven optimism. The company reported mixed Q2 2026 earnings, missing EPS estimates at $2.21 versus $2.23 expected, but maintains strong profitability with 54.23% gross margins and 21.01% net income margin. Recent news highlights a transformative $60 billion Amazon AI partnership, boosting data center ambitions beyond its core handset business.

QCOM's valuation appears reasonable with a P/E of 20.21, trading below the analyst consensus price target of $204.48. Key opportunities include AI data center growth and automotive expansion, while risks involve smartphone dependency and competitive pressures. Wall Street sentiment is mixed with 43.48% buy ratings, but the stock offers potential upside if AI bets materialize.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QCOM
56% Buy44% Sell
Avg holding period · 87 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About QUALCOMM, Inc.

Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.

Read more on QCOM →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →